メタ情報
| meta description平均長 | 166.5 |
|---|
| OGPありページ数 | 14 |
|---|
| Twitterカードありページ数 | 14 |
|---|
内部リンク分析（Internal）
| ユニーク内部リンク数 | 257 |
|---|
| ページあたり内部リンク平均 | 93.12 |
|---|
連絡先候補（Contacts）
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| our | 1 |
| sales | 0.96552 |
| nexel | 0.526647 |
| Neurosight | 0.526647 |
| Institute | 0.438873 |
| shipping | 0.438873 |
| company | 0.388324 |
| new | 0.388324 |
| Research | 0.358644 |
| world | 0.358644 |
| team | 0.358644 |
| Director | 0.351098 |
| available | 0.351098 |
| purchase | 0.351098 |
| can | 0.351098 |
| shipments | 0.351098 |
| website | 0.351098 |
| Hepatosight | 0.351098 |
| Cardiosight | 0.351098 |
| NMS | 0.351098 |
| Stem | 0.34245 |
| technology | 0.34245 |
| you | 0.333333 |
| Cell | 0.308205 |
| Development | 0.30741 |
| through | 0.291667 |
| quality | 0.263324 |
| order | 0.263324 |
| quantity | 0.263324 |
| reach | 0.263324 |
| out | 0.263324 |
| lot | 0.263324 |
| please | 0.263324 |
| business | 0.263324 |
| Nexel | 0.258882 |
| FDA | 0.258882 |
| Roadmap | 0.258882 |
| Way | 0.258882 |
| Safety | 0.258882 |
| Pharmacology | 0.258882 |
| researchers | 0.258882 |
| mission | 0.258882 |
| iPS | 0.258882 |
| closer | 0.258882 |
| Technologies | 0.256175 |
| Organoid | 0.256175 |
| Testing | 0.256175 |
| Human | 0.256175 |
| into | 0.256175 |
| within | 0.256175 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| Pharmacology | Safety | 2.790529 | 18 |
| cell | stem | 2.756674 | 24 |
| Cell | Stem | 2.700049 | 32 |
| nexel | sales | 2.486511 | 24 |
| Close | Password | 2.435947 | 12 |
| Better | Make | 2.306944 | 12 |
| Better | Place | 2.306944 | 12 |
| out | reach | 2.306944 | 12 |
| FDA | Roadmap | 2.256972 | 14 |
| sales | team | 2.217846 | 22 |
| Close | Confirm | 2.162375 | 9 |
| collaborators | valuable | 2.14417 | 11 |
| NMS | Neurosight | 2.072952 | 10 |
| Confirm | Password | 2.05362 | 9 |
| Safety | World | 2.038062 | 10 |
| Pharmacology | World | 2.038062 | 10 |
| Safety | Society | 2.038062 | 10 |
| Pharmacology | Society | 2.038062 | 10 |
| Methods | Testing | 2.011629 | 12 |
| first | password | 2.011629 | 12 |
| Password | first | 2.011629 | 12 |
| business | within | 2.011629 | 12 |
| Full | Secures | 1.994715 | 8 |
| Cycle | Full | 1.994715 | 8 |
| Disease | Modeling | 1.994715 | 8 |
| Animal | Reduce | 1.994715 | 8 |
| Establishing | Innovative | 1.994715 | 8 |
| Hopkins | Johns | 1.994715 | 8 |
| Microphysiological | Systems | 1.994715 | 8 |
| Sign | Systems | 1.994715 | 8 |
| MOU | Sign | 1.994715 | 8 |
| DNP | Japan | 1.994715 | 8 |
| DNP | collaborate | 1.994715 | 8 |
| begins | listing | 1.994715 | 8 |
| KOSDAQ | listing | 1.994715 | 8 |
| KOSDAQ | Submission | 1.994715 | 8 |
| Submission | request | 1.994715 | 8 |
| preliminary | request | 1.994715 | 8 |
| evaluation | preliminary | 1.994715 | 8 |
| Establishes | Nuoxinte | 1.994715 | 8 |
| Biotechnology | Nuoxinte | 1.994715 | 8 |
| Biotechnology | Branch | 1.994715 | 8 |
| Branch | Suzhou | 1.994715 | 8 |
| China | Suzhou | 1.994715 | 8 |
| Passes | Technology | 1.994715 | 8 |
| Evaluation | Technology | 1.994715 | 8 |
| BioHealth | Evaluation | 1.994715 | 8 |
| Best | BioHealth | 1.994715 | 8 |
| Best | Companies | 1.994715 | 8 |
| Awards | Companies | 1.994715 | 8 |